ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.88463
-0.01%
Brent Oil
83.435
-0.05%
Bitcoin
63,727.10
0.89%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Endologix Inc (ELGX)

  7. Endologix Inc (ELGX) Noticias

ELGX

Endologix (ELGX)

Endologix Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ELGX
FechaHoraFuenteTítuloSímboloCompañía
05/10/202005:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ELGXEndologix Inc
01/10/202014:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELGXEndologix Inc
01/10/202012:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELGXEndologix Inc
01/10/202011:04Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELGXEndologix Inc
01/10/202010:51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELGXEndologix Inc
01/10/202010:22Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ELGXEndologix Inc
17/09/202015:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELGXEndologix Inc
14/08/202016:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ELGXEndologix Inc
10/08/202005:17Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ELGXEndologix Inc
10/07/202015:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ELGXEndologix Inc
05/07/202021:35Business Wire Endologix Enters into an Agreement with Deerfield Partners to Take the Company PrivateNASDAQ:ELGXEndologix Inc
25/06/202007:00PR Newswire (US)Sight Sciences Strengthens Its Leadership Team with Chief Operating Officer and General Counsel HiresNASDAQ:ELGXEndologix Inc
18/06/202015:30Business WireEndologix Announces Departure of CFO and Appointment of Interim CFONASDAQ:ELGXEndologix Inc
15/06/202015:01Business WireEndologix Issues Correction Notice for Ovation iX Abdominal Stent Graft SystemNASDAQ:ELGXEndologix Inc
28/05/202015:10Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELGXEndologix Inc
27/05/202008:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ELGXEndologix Inc
11/05/202015:03Business WireEndologix Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Ane...NASDAQ:ELGXEndologix Inc
11/05/202015:01Business WireEndologix Reports First Quarter 2020 Financial ResultsNASDAQ:ELGXEndologix Inc
01/05/202015:01Business WireEndologix, Inc. to Announce First Quarter 2020 Financial Results on May 11, 2020NASDAQ:ELGXEndologix Inc
27/04/202015:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ELGXEndologix Inc
14/04/202015:01Business WireEndologix Appoints Tim A. Benner as Chief Commercial OfficerNASDAQ:ELGXEndologix Inc
06/04/202007:00Business WireEndologix Announces Preliminary Financial Results for First Quarter 2020NASDAQ:ELGXEndologix Inc
30/03/202007:00Business WireEndologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ELGXEndologix Inc
17/03/202017:30Business WireEndologix Adds Jane E. Kiernan to its Board of DirectorsNASDAQ:ELGXEndologix Inc
16/03/202008:00Business WireEndologix Receives FDA Approval for Alto Abdominal Stent Graft SystemNASDAQ:ELGXEndologix Inc
11/03/202016:15Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ELGXEndologix Inc
24/02/202007:55Business WireEndologix Announces Debt Restructuring Addressing 2020 MaturitiesNASDAQ:ELGXEndologix Inc
19/02/202015:01Business WireEndologix Reports Fourth Quarter and Fiscal Year 2019 Financial ResultsNASDAQ:ELGXEndologix Inc
18/02/202007:00Business WireEndologix, Inc. to Present at the SVB Leerink Global Healthcare ConferenceNASDAQ:ELGXEndologix Inc
14/02/202015:57Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELGXEndologix Inc
 Showing the most relevant articles for your search:NASDAQ:ELGX

Su Consulta Reciente

NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURUSD
Euro vs US Dollar
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
VZ
Verizon Communications
USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados